FEDERAL COURT OF AUSTRALIA
Albany Molecular Research Inc v Arrow Pharmaceuticals Pty Ltd [2011] FCA 252
Citation: Albany Molecular Research Inc v Arrow Pharmaceuticals Pty Ltd [2011] FCA 252 Parties: ALBANY MOLECULAR RESEARCH, INC v ARROW PHARMACEUTICALS PTY LTD (ACN 003 144 170), SIGMA PHARMACEUTICALS LIMITED (ACN 088 417 403), SIGMA PHARMACEUTICALS (AUSTRALIA) PTY LTD (ACN 004 118 594), SIGMA COMPANY LIMITED (ACN 004 132 923) and AVENTIS PHARMACEUTICALS, INC File number: VID 883 of 2007 Judge: JESSUP J Date of judgment: 23 March 2011 Legislation: Patents Act 1990 (Cth) s 138 Cases cited: Albany Molecular Research Inc v Alphapharm Pty Ltd [2011] FCA 120 Date of last submissions: 11 March 2011 Place: Melbourne Division: GENERAL DIVISION Category: No Catchwords Number of paragraphs: 6 Counsel for the Applicant: Mr A Archibald QC with Mr A Ryan SC and Ms K Beattie Solicitor for the Applicant: Phillips Ormonde Fitzpatrick Counsel for the Respondents: Mr D Shavin QC wth Ms H Rofe Solicitor for the Respondents: Corrs Chambers Westgarth
IN THE FEDERAL COURT OF AUSTRALIA
VICTORIA DISTRICT REGISTRY
GENERAL DIVISION
VID883 of 2007
BETWEEN: ALBANY MOLECULAR RESEARCH INC
Applicant/First Cross-RespondentAVENTIS PHARMACEUTICALS, INC
Second Cross-RespondentAND: ARROW PHARMACEUTICALS PTY LTD (ACN 003 144 170)
First Respondent/First Cross-ClaimantSIGMA PHARMACEUTICALS LIMITED (ACN 088 417 403)
Third Respondent/Third Cross-ClaimantSIGMA PHARMACEUTICALS (AUSTRALIA) PTY LTD (ACN 004 118 594)
Fourth Respondent/Fourth Cross-ClaimantSIGMA COMPANY LIMITED (ACN 004 132 923)
Fifth Respondent/Fifth Cross-Claimant
JUDGE:
JESSUP J
DATE OF ORDER:
23 MARCH 2011
WHERE MADE:
MELBOURNE
THE COURT ORDERS THAT:
1.The application be dismissed.
THE COURT DECLARES THAT:
2.So far as it relates to Claims 1, 6, 7, 8, 9 and 10, Australian patent No 699799 is invalid.
THE COURT FURTHER ORDERS THAT:
3.So far as it relates to Claims 1, 6, 7, 8, 9 and 10, Australian patent No 699799 be revoked.
4.Upon the applicant by its counsel undertaking –
(a) to prosecute any appeal expeditiously;
(b)during the period of the stay, not to threaten any person with proceedings for infringement of claims 1, 6, 7, 8, 9 or 10 of the said patent; and
(c)during the period of the stay, not to seek to amend any claims of the said patent otherwise than in the course of or in connection with this proceeding;
the operation of Order 3 above be stayed –
(i)for 28 days; and
(ii)if the applicant has within that 28‑day period, lodged an appeal against the making of that order, until the hearing and determination thereof or further order.
5.The cross-claim otherwise be dismissed.
6.The parties file and serve their written submissions on costs as follows:
(a) the respondents/cross-claimants, within seven days;
(b)the applicant/cross-respondents, within a further seven days;
(c)the respondents/cross-claimants in reply (if required), within a further seven days.
Note:Settlement and entry of orders is dealt with in Order 36 of the Federal Court Rules.
The text of entered orders can be located using Federal Law Search on the Court’s website.
IN THE FEDERAL COURT OF AUSTRALIA
VICTORIA DISTRICT REGISTRY
GENERAL…
Keep reading for free
Create a free CaseChat account to read Albany Molecular Research Inc v Arrow Pharmaceuticals Pty Lt... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2011] FCA 252
- Decision Date
CaseChat Overview and Summary
The primary legal issues that the court had to resolve included whether certain claims in the patent were valid and whether Arrow had infringed those claims. Specifically, the court had to determine the scope and validity of claims 1, 6, 7, 8, 9, and 10 of the patent. The court also had to consider the cross-claim brought by Arrow for a declaration of invalidity and any costs associated with the proceedings.
After thorough examination of the evidence and arguments presented by both parties, the court found that claims 1, 6, 7, 8, 9, and 10 of the patent were invalid due to issues of obviousness and lack of novelty. Consequently, the court declared these claims invalid and ordered the revocation of the patent in relation to those claims. However, the court stayed the operation of the revocation order for 28 days, and further if an appeal was lodged within that period, until the appeal was heard and determined, provided that certain conditions were met by Albany. These conditions included prosecuting any appeal expeditiously, refraining from threatening infringement proceedings during the stay period, and not seeking to amend the patent claims outside the scope of the current proceedings. The court dismissed the cross-claim brought by Arrow. Finally, the court directed the parties to submit written costs submissions within specified timeframes.
Orders
Orders of the court
1. The application be dismissed.
THE COURT DECLARES THAT:
2. So far as it relates to Claims 1, 6, 7, 8, 9 and 10, Australian patent No 699799 is invalid.
THE COURT FURTHER ORDERS THAT:
3. So far as it relates to Claims 1, 6, 7, 8, 9 and 10, Australian patent No 699799 be revoked.
4. Upon the applicant by its counsel undertaking –
(a) to prosecute any appeal expeditiously;
(b) during the period of the stay, not to threaten any person with proceedings for infringement of claims 1, 6, 7, 8, 9 or 10 of the said patent; and
(c) during the period of the stay, not to seek to amend any claims of the said patent otherwise than in the course of or in connection with this proceeding;
the operation of Order 3 above be stayed –
(i) for 28 days; and
(ii) if the applicant has within that 28‑day period, lodged an appeal against the making of that order, until the hearing and determination thereof or further order.
5. The cross-claim otherwise be dismissed.
6. The parties file and serve their written submissions on costs as follows:
(a) the respondents/cross-claimants, within seven days;
(b) the applicant/cross-respondents, within a further seven days;
(c) the respondents/cross-claimants in reply (if required), within a further seven days.
Note:
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.